Le Wang,John K. Pratt,Keith F. McDaniel,Yujia Dai,Steven D. Fidanze,Lisa Hasvold,James H. Holms,Warren M. Kati,Dachun Liu,Robert A. Mantei,William J. McClellan,George S. Sheppard,Carol K. Wada
申请号：
US15008994
公开号：
US20160143916A1
申请日:
2016.01.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides for compounds of formula (I)wherein A1, A2, A3, A4, X1, X2, Y1, L1, G1, Rx, and Ry have any of the values defined thereof in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
